[AXIATA] QoQ Cumulative Quarter Result on 31-Dec-2010 [#4]

Stock
[AXIATA] AXIATA GROUP BERHAD
Announcement Date
23-Feb-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Dec-2010 [#4]
Profit Trend
QoQ- -17.17%
YoY- 7.12%
Quarter Report
Latest QR
Upcoming QR
AXIATA's Result
AXIATA's Financial Summary
View:
Show?
Cumulative Result
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Revenue 12,183,648 7,989,141 3,940,382 15,620,674 11,603,959 7,666,754 3,812,685 116.79%
PBT 2,876,253 1,912,938 902,210 3,205,738 3,232,513 2,188,388 1,217,411 77.29%
Tax -790,916 -506,742 -261,061 -1,089,158 -855,176 -556,218 -260,753 109.39%
NP 2,085,337 1,406,196 641,149 2,116,580 2,377,337 1,632,170 956,658 68.03%
-
NP to SH 1,801,042 1,211,416 548,365 1,770,379 2,137,419 1,498,293 921,475 56.26%
-
Tax Rate 27.50% 26.49% 28.94% 33.98% 26.46% 25.42% 21.42% -
Total Cost 10,098,311 6,582,945 3,299,233 13,504,094 9,226,622 6,034,584 2,856,027 131.91%
-
Net Worth 19,554,170 19,469,185 20,746,475 18,715,435 19,493,261 18,562,185 18,345,730 4.34%
Dividend
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Div - 346,118 - 843,037 - - - -
Div Payout % - 28.57% - 47.62% - - - -
Equity
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Net Worth 19,554,170 19,469,185 20,746,475 18,715,435 19,493,261 18,562,185 18,345,730 4.34%
NOSH 8,576,390 8,652,971 9,139,416 8,430,376 8,549,676 8,323,850 8,377,045 1.57%
Ratio Analysis
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
NP Margin 17.12% 17.60% 16.27% 13.55% 20.49% 21.29% 25.09% -
ROE 9.21% 6.22% 2.64% 9.46% 10.96% 8.07% 5.02% -
Per Share
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
RPS 142.06 92.33 43.11 185.29 135.72 92.11 45.51 113.44%
EPS 21.00 14.00 6.00 21.00 25.00 18.00 11.00 53.83%
DPS 0.00 4.00 0.00 10.00 0.00 0.00 0.00 -
NAPS 2.28 2.25 2.27 2.22 2.28 2.23 2.19 2.71%
Adjusted Per Share Value based on latest NOSH - 9,176,000
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
RPS 132.68 87.00 42.91 170.11 126.37 83.49 41.52 116.79%
EPS 19.61 13.19 5.97 19.28 23.28 16.32 10.03 56.29%
DPS 0.00 3.77 0.00 9.18 0.00 0.00 0.00 -
NAPS 2.1294 2.1202 2.2593 2.0381 2.1228 2.0214 1.9978 4.34%
Price Multiplier on Financial Quarter End Date
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Date 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 31/03/10 -
Price 4.60 5.01 4.79 4.75 4.38 3.92 3.85 -
P/RPS 3.24 5.43 11.11 2.56 3.23 4.26 8.46 -47.23%
P/EPS 21.90 35.79 79.83 22.62 17.52 21.78 35.00 -26.82%
EY 4.57 2.79 1.25 4.42 5.71 4.59 2.86 36.63%
DY 0.00 0.80 0.00 2.11 0.00 0.00 0.00 -
P/NAPS 2.02 2.23 2.11 2.14 1.92 1.76 1.76 9.61%
Price Multiplier on Announcement Date
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Date 30/11/11 23/08/11 31/05/11 23/02/11 24/11/10 25/08/10 27/05/10 -
Price 5.10 4.98 5.00 4.95 4.49 4.42 3.69 -
P/RPS 3.59 5.39 11.60 2.67 3.31 4.80 8.11 -41.88%
P/EPS 24.29 35.57 83.33 23.57 17.96 24.56 33.55 -19.35%
EY 4.12 2.81 1.20 4.24 5.57 4.07 2.98 24.07%
DY 0.00 0.80 0.00 2.02 0.00 0.00 0.00 -
P/NAPS 2.24 2.21 2.20 2.23 1.97 1.98 1.68 21.12%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment